Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 1 Patient and Treatment Characteristics

From: Early observed transient prostate-specific antigen elevations on a pilot study of external beam radiation therapy and fractionated MRI guided High Dose Rate brachytherapy boost

  Patients Without PSA Bounce (n = 4) Patients With PSA Bounce (n = 5) P Value
Median Age (years) 67 62 NS
Largest Field Treated    
Whole Pelvis Treated 0% 20% NS
Prostate and Seminal Vesicles 75% 40% NS
Prostate Only 25% 40% NS
Concurrent Hormone Therapy 25% 60% NS
T2b and greater tumor stage 0% 20% NS
PSA less than 10 75% 80% NS